ENVALITH
昭和化学工業株式会社 logo

Showa Chemical Industry Co., Ltd.

4990Standard MarketChemicals

昭和化学工業株式会社 logo
Showa Chemical Industry Co., Ltd.4990

Business

Showa Chemical Industry Co., Ltd. (Diatomaceous Earth & Perlite Business) is a company listed on the Tokyo Stock Exchange Standard Market, founded in 1933, operating as a single-segment business that manufactures and sells Filter Aids, Building Materials & Fillers, Chemical Products, and Other Products using diatomaceous earth and perlite as primary raw materials. The company has three consolidated subsidiaries (Hakusan Kogyo, Nissho, and Beijing Ruilaite Trading) and two equity-method affiliates (Hakusanshi Chofuen Tsu Mining and Obex), building a production and sales network both domestically and overseas. Its major customers span the food and industrial sectors, including beer, soft drinks, pharmaceuticals, and chemical industries, as well as housing materials and water treatment-related businesses. Filter Aids, its core product line, accounts for 61.7% of net sales, with Building Materials & Fillers at 16.1% and Chemical Products at 16.2%, reflecting a diversified product portfolio.

Business Model

Building on diatomaceous earth and perlite production at the company's own plants (Akita, Okayama, Tochigi, etc.), the company has established a vertically integrated supply chain that combines manufacturing outsourcing to consolidated subsidiaries with raw material procurement from equity-method affiliates. In addition to product sales, the company promotes continued customer usage through technical proposals and solutions leveraging its Research & Analysis Center. Chemical Products adopts a purchase-and-resale model, and the company has a composite earnings structure in which investment gains from equity-method affiliate Auvex also contribute to ordinary profit.

Company Strengths

Since its founding in 1933, the company has consistently engaged in the manufacture and sale of diatomaceous earth and perlite filter aids, accumulating domestic and overseas verification data for agricultural products, obtaining related patents, and receiving certification as a Ministry of the Environment "Nature Symbiosis Site" in December 2025. This long-accumulated technical and quality control know-how forms an entry barrier that is difficult for competitors to replicate in a short period.

In addition to domestic plants in Akita, Okayama, and Tochigi, the company operates overseas bases in China, Singapore, and Dalian (established October 2025). By combining outsourced manufacturing to consolidated subsidiary Hakusan Kogyo with raw material procurement from equity-method affiliates, the company has secured a stable supply system and BCP capability. Capital expenditures for FY2026 (ending March 2026) reached ¥375 million, reflecting continuous renewal of production facilities.

As of the end of FY2026 (ending March 2026), the equity ratio stood at 64.4% (improved from 59.5% in the previous fiscal year), with net assets of ¥9,387 million against total assets of ¥14,569 million. The company held cash and cash equivalents of ¥2,873 million, and its financial base was further strengthened by an expansion of unrealized gains on investment securities (valuation difference on available-for-sale securities increased by ¥643 million). The medium-term management plan also sets a policy of maintaining an equity ratio of 50% or above.

ENVALITH's Perspective

Operating profit for FY2026 (ending March 2026) rose 29.0% year on year to ¥446 million, marking a recovery, but this remains at just 74% of the FY2023 (ending March 2023) peak level (¥601 million). Net sales stayed flat for the fifth consecutive period at ¥9,272 million (up 0.4% year on year), with the core Filter Aids business declining 1.0% year on year amid continued softness in overseas markets. While the improvement in the cost of sales ratio (from 69.2% to 68.2%) is commendable, expanding sales scale remains essential for restoring the core business's earning power.

For the FY2027 (ending March 2027) earnings forecast, the company has disclosed only net sales of ¥9,400 million and operating profit of ¥200 million, citing the undetermined earnings forecast of its equity-method affiliate Obex Inc.; ordinary profit and net income forecasts have not been disclosed. The operating profit forecast implies a sharp 55.2% year-on-year decline, suggesting concerns over deteriorating core business profitability compounded by uncertainty regarding equity-method income. This continues to make it difficult for investors to grasp the overall earnings picture, highlighting the need for improved transparency in disclosure.

The formulation and announcement of a new medium-term management plan dated May 15, 2026 is commendable in that it indicates the company's medium- to long-term growth direction. On the other hand, the earnings report does not disclose specific numerical targets or details of measures under the plan, while external factors such as geopolitical risks (the situation in Ukraine and the Middle East) and the weak yen and global inflationary trends are heightening uncertainty in the business environment. The dividend was increased from ¥6 in the previous period to ¥10, but the forecast for the next period calls for a reduction to ¥6, warranting attention to the stability of shareholder returns.

Growth Strategy

Sustainable growth through deepening existing businesses, cultivating new businesses, cost reductions, and the new medium-term management plan

Executed tangible fixed asset acquisitions of ¥390 million (FY2026 (ending March 2026)) to strengthen business earnings from a long-term perspective. Aims to maintain and reinforce the production base through renewal investment in buildings and machinery and equipment.

In addition to promoting continued product use through technical support provided to customers, new business activities are being developed. Sales increases in Chemical Products (up 2.1% year on year) and Building Materials & Fillers (up 4.8% year on year) show some tangible results.

A new medium-term management plan was formulated and announced on May 15, 2026. The policy is to promote various measures including aggressive sales expansion activities, cultivation of new businesses, company-wide cost reductions, and reduction of disaster risk. Please refer to separately disclosed materials for specific numerical targets.

Equity in earnings of affiliates expanded to ¥163 million (approximately 3.8 times year on year) in FY2026 (ending March 2026). Diversification of earnings through the business contribution of affiliated companies continues, but difficulty in reasonably estimating the next period's earnings forecast remains a challenge.

Last updated: July 19, 2026